People
Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics.
Nicholas W. Alexos will assume position of chief financial officer effective November 10, 2017.
The SAB includes experts in vaccines and preventative health from leading academic/ research and international health organisations in the US and Europe.
Another top executive at Glaxo is leaving the company as new CEO Emma Walmsley continues to shape the c-suite for her administration.
The scientist was among the nearly one dozen people injured on Oct. 31.
Anders Gotzsche will serve as interim CEO while the company looks for a replacement for Kare Schultz who leaves the company Oct. 31 for the CEO position at Teva.
Vikram Bajaj joined Grail only a year ago.
Insys continues to receive an optics beating in the wake of the charges against company founder John Kapoor and multiple executives surrounding illegal sales practices of its cancer pain drug.
On multiple occasions, President Donald Trump has aimed his ire at pharma companies.
After four months of looking, Five Prime Therapeutics has found its new CEO.
PRESS RELEASES